United Therapeutics | UTHR - Ordinary Share Capital


United Therapeutics reported $42.16M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Amarin USD 20.81M 13K Dec/2025
Ardelyx USD 246.97M 2.62M Mar/2026
Baxter International USD 517M 549K Jun/2026
Bayer EUR 982.42M 0 Mar/2026
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Emergent BioSolutions USD 100K 0 Jun/2023
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Halozyme Therapeutics USD 118.52M 741K Mar/2026
Insmed USD 216.52M 2.27M Mar/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
Moderna USD 391M 2M Sep/2025
Omeros USD 611K 17K Dec/2023
Pfizer USD 5.7B 13M Mar/2026
PTC Therapeutics USD 82.88M 1.41M Mar/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Sarepta Therapeutics USD 105.57M 607K Mar/2026
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
Vertex Pharmaceuticals USD 253.3M 900K Jun/2026